Mosaic vaccine-induced antibody-dependent cellular phagocytosis associated with delayed HIV-1 viral load rebound post treatment interruption

被引:0
|
作者
Mdluli, Thembi [1 ,2 ]
Slike, Bonnie M. [1 ,2 ]
Curtis, Daniel J. [1 ,2 ]
Shubin, Zhanna [1 ,2 ,6 ]
Tran, Ursula [1 ,2 ]
Li, Yifan [1 ,2 ]
Dussupt, Vincent [1 ,2 ]
Mendez-Rivera, Letzibeth [1 ,2 ]
Pinyakorn, Suteeraporn [1 ,2 ]
Stieh, Daniel J. [3 ]
Tomaka, Frank L. [4 ]
Schuitemaker, Hanneke [3 ]
Pau, Maria G. [3 ]
Colby, Donn J. [1 ,2 ,5 ]
Kroon, Eugene [5 ]
Sacdalan, Carlo [5 ]
de Souza, Mark [5 ]
Phanupak, Nittaya [5 ]
Hsu, Denise C. [1 ,2 ]
Ananworanich, Jintanat [1 ,2 ]
Ake, Julie A. [1 ]
Trautmann, Lydie [1 ,2 ]
Vasan, Sandhya [1 ,2 ]
Robb, Merlin L. [1 ,2 ]
Krebs, Shelly J. [1 ]
Paquin-Proulx, Dominic [1 ,2 ]
Rolland, Morgane [1 ,2 ]
机构
[1] US Mil HIV Res Program MHRP, CIDR, Walter Reed Army Inst Res, Silver Spring, MD 20910 USA
[2] Henry M Jackson Fdn Advancement Mil Med, Bethesda, MD 20817 USA
[3] Janssen Vaccines & Prevent BV, NL-2333 CN Leiden, Netherlands
[4] Janssen R&D US, Titusville, NJ USA
[5] Inst HIV Res & Innovat, SEARCH, Bangkok 10330, Thailand
[6] US FDA, Silver Spring, MD 20903 USA
来源
CELL REPORTS | 2024年 / 43卷 / 06期
关键词
ANTIRETROVIRAL THERAPY; PROTECTIVE EFFICACY; LATENT RESERVOIR; HIGH-THROUGHPUT; CHALLENGES; STABILITY;
D O I
10.1016/j.celrep.2024.114344
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
A heterologous Ad26/MVA vaccine was given prior to an analytic treatment interruption (ATI) in people living with HIV -1 (mainly CRF01_AE) who initiated antiretroviral treatment (ART) during acute HIV -1. We investigate the impact of Ad26/MVA vaccination on antibody (Ab)-mediated immune responses and their effect on time to viral rebound. The vaccine mainly triggers vaccine -matched binding Abs while, upon viral rebound post ATI, infection -specific CRF01_AE binding Abs increase in all participants. Binding Abs are not associated with time to viral rebound. The Ad26/MVA mosaic vaccine profile consists of correlated non-CRF01_AE binding Ab and Fc effector features, with strong Ab-dependent cellular phagocytosis (ADCP) responses. CRF01_AE-specific ADCP responses (measured either prior to or post ATI) are significantly higher in individuals with delayed viral rebound. Our results suggest that vaccines eliciting cross -reactive responses with circulating viruses in a target population could be beneficial and that ADCP responses may play a role in viral control post treatment interruption.
引用
收藏
页数:15
相关论文
共 4 条
  • [1] Monocyte-derived transcriptome signature indicates antibody-dependent cellular phagocytosis as a potential mechanism of vaccine-induced protection against HIV-1
    Shangguan, Shida
    Ehrenberg, Philip K.
    Geretz, Aviva
    Yum, Lauren
    Kundu, Gautam
    May, Kelly
    Fourati, Slim
    Nganou-Makamdop, Krystelle
    Williams, LaTonya D.
    Sawant, Sheetal
    Lewitus, Eric
    Pitisuttithum, Punnee
    Nitayaphan, Sorachai
    Chariyalertsak, Suwat
    Rerks-Ngarm, Supachai
    Rolland, Morgane
    Douek, Daniel C.
    Gilbert, Peter
    Tomaras, Georgia D.
    Michael, Nelson L.
    Vasan, Sandhya
    Thomas, Rasmi
    ELIFE, 2021, 10
  • [2] HIV-1 antibody 3BNC117 suppresses viral rebound in humans during treatment interruption
    Scheid, Johannes F.
    Horwitz, Joshua A.
    Bar-On, Yotam
    Kreider, Edward F.
    Lu, Ching-Lan
    Lorenzi, Julio C. C.
    Feldmann, Anna
    Braunschweig, Malte
    Nogueira, Lilian
    Oliveira, Thiago
    Shimeliovich, Irina
    Patel, Roshni
    Burke, Leah
    Cohen, Yehuda Z.
    Hadrigan, Sonya
    Settler, Allison
    Witmer-Pack, Maggi
    West, Anthony P., Jr.
    Juelg, Boris
    Keler, Tibor
    Hawthorne, Thomas
    Zingman, Barry
    Gulick, Roy M.
    Pfeifer, Nico
    Learn, Gerald H.
    Seaman, Michael S.
    Bjorkman, Pamela J.
    Klein, Florian
    Schlesinger, Sarah J.
    Walker, Bruce D.
    Hahn, Beatrice H.
    Nussenzweig, Michel C.
    Caskey, Marina
    NATURE, 2016, 535 (7613) : 556 - +
  • [3] Higher HIV-1 Env gp120-Specific Antibody-Dependent Cellular Cytotoxicity (ADCC) Activity Is Associated with Lower Levels of Defective HIV-1 Provirus
    Yucha, Ryan
    Litchford, Morgan L.
    Fish, Carolyn S.
    Yaffe, Zak A.
    Richardson, Barbra A.
    Maleche-Obimbo, Elizabeth
    John-Stewart, Grace
    Wamalwa, Dalton
    Overbaugh, Julie
    Lehman, Dara A.
    VIRUSES-BASEL, 2023, 15 (10):
  • [4] Antibody-Dependent Cellular Phagocytosis of HIV-1-Infected Cells Is Efficiently Triggered by IgA Targeting HIV-1 Envelope Subunit gp41
    Duchemin, Maxence
    Tudor, Daniela
    Cottignies-Calamarte, Andrea
    Bomsel, Morgane
    FRONTIERS IN IMMUNOLOGY, 2020, 11